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Background: The National Health and Family Planning Commission of China has issued more than 400 clinical
pathways to improve the effectiveness and efficiency of medical care delivered by public hospitals in China. The
aim of our study is to determine whether patient care is compliant with national clinical pathways in public general
hospitals of Pudong New Area in Shanghai.
Methods: We identified the clinical pathways established by the National Health and Family Planning Commission
of China for 5 common conditions (community-acquired pneumonia, acute myocardial infarction (AMI), heart
failure, cesarean section, type-2 diabetes). We randomly selected patients with each condition admitted to one of 7
public general hospitals in Pudong New Area in China in January, 2013. We identified key process indicators (KPIs)
for each pathway and, based on chart review for each patient, determined whether the patient’s care was
compliant for each indicator. We calculated the proportion of care which was compliant with clinical pathways for
each indicator, the average proportion of indicators that were met for each patient, and the proportion of patients
whose care was compliant for all measures. For selected indicators, we compared compliance rates among
hospitals in our study with those from other countries.
Results: Average compliance rates across the KPIs for each condition ranged from 61 % for AMI to 89 % for
pneumonia. The percent of patient receiving fully compliant care ranged from 0 for AMI and heart failure to 39 %
for pneumonia. Compared to the compliance rate for process indicators in the hospitals of other countries, some
rates in the hospitals that we audited were higher, but some were lower.
Conclusions: Few patients received care that complied with all the pathways for each condition. The reasons for
low compliance with national clinical pathways and how to improve clinical quality in public hospitals of China
need to be further explored.
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Ensuring that hospitals consistently provide high quality
care is a challenge facing policymakers and hospital
administrators around the world. The quality of hospital
care is an important issue for policy makers in China as
patients are increasingly demanding higher quality care.
A key component of national policies intended to im-
prove quality of care has been the development and use
of clinical pathways.* Correspondence: xuedi@shmu.edu.cn
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has increased rapidly in China in recent years. The National
Health and Family Planning Commission (NHFPC, previ-
ously called “Ministry of Health”) of China has issued more
than 400 clinical pathways [1]. Despite the emphasis placed
on the use of pathways, there is little evidence on the extent
to which Chinese hospitals provide care consistent with
these pathways [2].Clinical guidelines and pathways
Clinical guidelines are recommendations on the appro-
priate treatment and care of people with specific dis-
eases and conditions [3]. Clinical pathways, in contrast,
support the translation of clinical guidelines into localistributed under the terms of the Creative Commons Attribution 4.0
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translate the clinical guideline into practice in a par-
ticular local environment [4]. By linking evidence to
clinical practice, the use of clinical pathways is intended
to optimize patient outcomes and increase clinical effi-
ciency [4].
In China, national medical associations generally cre-
ate clinical guidelines and the NHFPC translates the
guidelines into clinical pathways. In 2012, the NHFPC
required every tertiary- and secondary-level hospital in
China to implement at least 60 clinical pathways, with at
least 40 from among the over 400 established by the
NHFPC, although the hospitals may customize the path-
ways for their patients. In this study, we examine the
extent to which the care provided by public hospitals in
Shanghai is consistent with national clinical pathways.
Effects of clinical guidelines and pathways
Studies have documented an association between the use
of clinical guidelines and pathways and positive outcomes
including the provision of high-quality, cost-effective care,
greater patient and staff satisfaction, and better resource
management in a variety of clinical contexts [4–7]. Other
studies have documented that the adoption of clinical
pathways can reduce length of stay and decrease medical
cost [8–10].
In this study, we document the clinical pathways
established by the NHFCP for five clinical conditions:
community-acquired pneumonia (“pneumonia”), AMI,
heart failure, cesarean section, type-2 diabetes. Clinical
guidelines or pathways have been shown to be effect-
ive in these clinical contexts. Guideline-concordant
therapy for community-acquired pneumonia is associ-
ated with improved health outcomes and the use of
fewer resources [11, 12]. Compliance with acute myo-
cardial infarction (AMI) guidelines is associated with
lower inpatient mortality [13–15] and the implemen-
tation of a clinical pathway for heart failure was asso-
ciated with improvements in care processes as well as
reduced length of stay and hospital charges [16, 17]. A
study of the implementation of National Institute for
Health and Clinical Excellence (NICE) guidance re-
garding caesarean section documented lower rates of
surgical site infection following caesarean section [18].
In the context of diabetes, the implementation of a
process improvement effort using practice guidelines
resulted in greater compliance with recommended
HbA1c, lipid, blood pressure, and foot checks, leading to
better control of blood pressure and lower body mass
index (BMI) [19]. Despite the potential for adherence to
clinical guidelines to reduce mortality and morbidity and
decrease healthcare costs, there is substantial evidence
that adherence to guidelines in clinical practice is often
poor [13, 14, 20–22].In our analysis, we measure the extent to which the
care patients received was compliant with the national
clinical pathways for these conditions in public general
hospitals of Pudong New Area in Shanghai. We identify
key process indicators (KPIs) for each condition based
on the clinical pathways and then determine whether
the care of randomly selected patients with each condi-
tion was consistent with these indicators. We also com-
pare performance on several clinical pathways with results
from studies of other countries.
Our study is the first to document the extent to which
public hospitals in China are adhering to national guide-
lines. The study provides important baseline information
on the delivery of health care in Chinese public hospitals
and the potential for improvements in health care quality.Methods
Survey sample
We studied physician compliance with the national clin-
ical pathways in all seven public, general hospitals in
Pudong New Area of Shanghai. We chose to study 5 con-
ditions: pneumonia, AMI, heart failure, cesarean section,
and type-2 diabetes. These conditions were among the top
ten in patient volume in all the surveyed hospitals and had
national clinical pathways published by NHFPC [23].
Using hospital information systems, we identified all
patients with a given diagnosis, based on inpatient inter-
national classification of diseases (ICD-10 or ICD-9)
codes, admitted to each hospital during 2012 for each
condition. To ensure that the sample was evenly distrib-
uted throughout the year, we randomly selected the first
two inpatient admissions with an odd patient number
for each condition in each month. If a hospital admitted
fewer than 24 patients for a particular condition in 2012,
then all the medical records for this condition were ex-
tracted for this hospital.Data sources
We developed an audit chart for each of the five condi-
tions based on the clinical pathways published by NHFPC.
The audit chart identified the key process components in
the clinical pathway, focusing on those both that were
important determinants of quality of care and for which
data was likely to be available in medical records. We then
extracted data from the medical records corresponding to
each item in the audit chart for each patient.
To ensure the quality and consistency of chart audit,
we trained five researchers on the meanings of each item
on the checklist and how to audit each chart. The re-
searchers then observed two experts auditing charts to
assess compliance for heart failure and cesarean section
pathways in one hospital and subsequently audited the
same charts the experts audited. The consistency between
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was 87 %.
For each admission, we also collected data on patient
demographics and health status as well as some financial
information from the hospital information systems (HIS)
of the surveyed hospitals.Selection of key process indicators
The national clinical pathways are very detailed and
when we abstracted data, we tried to gather information
on each step. When reporting the results, we chose to
focus on the more clinically meaningful components of
each pathway (see Additional file 1). For example, in the
pneumonia pathway, we focused on severity assessment
and corresponding treatment, appropriate use of antibi-
otics, health education, and appropriate length of stay.
We did not include appropriateness of admission as a
KPI. Similarly, for AMI, we focused on timely treatment
and evaluation of left ventricular function, appropriate
use of medicine (such as aspirin/clopidogrel, β-blocker,
ACEI/ARB, statins), reperfusion therapy, thrombolytic
therapy and health education, because they are life-
saving and important for secondary disease preventions.
We did not include length of stay for AMI due to the
potential for differences across patients in appropriate
length of stay.Table 1 Compliance rates for KPIs for inpatient care of
pneumonia (n = 151)a




1 Patient severity assessed 151 95
2 Severe patients (oxygen saturation <92 %)
received blood gas analysis
151 70
3 Timeliness of sputum and blood culture 151 77Data analysis
We coded hospitals as compliant for an indicator only if
the information was recorded in the medical record and
the care was consistent with the clinical pathway or if
the medical record included a reasonable explanation for
not being compliant. For each KPI, we calculated the
proportion of patients who received compliant care.
From this information, we also calculated two patient-
level measures of compliance: 1) whether the patient
received pathway compliant care for all indicators (fully
compliant care) and 2) the proportion of KPIs that were
met for the patient. We used these patient-level mea-
sures to calculate the proportion of patients receiving
fully compliant care (full compliance rate) for each con-
dition and the average of the proportion of KPIs that
were met over all patients with a given condition (aver-
age compliance rate).4 Timely and appropriate use of antibiotics
within 4 h
150 92
5 Appropriate treatment update at 72 h 151 98
6 Antibiotic treatment is reasonable
(7 ~ 14 days)
151 81
7 Received health education 151 98Ethics approval
This study was approved by Institutional Review Board,
School of Public Health, Fudan University (IRB#2012-
11-0383).8 Appropriate length of stay 151 100
Average 89
aKPIs key process indicatorsConsent statement
N/A for this retrospective study.Results
The numbers of medical records audited across all hos-
pitals in the study were 151, 97, 145, 146 and 137 for
pneumonia, AMI, heart failure, caesarean section, and
type-2 diabetes, respectively (Tables 1, 2, 3, 4 and 5).Compliance rates
Compliance rates for the KPIs for pneumonia ranged
from 70 to 100 %. All the patients with pneumonia had
appropriate length of stay according the pathway, but
the compliance rate for “Severe patients (defined as
oxygen saturation < 92 %) received blood gas analysis”
was 70 %. The proportion of patients who received ini-
tial antibiotics properly within 4 h of hospital arrival in
our study was 92 % (Table 1).
The compliance rates for the AMI KPIs ranged from 0
to 94 %. The lowest three compliance rates were for
“Reassessment of patient condition within 1 week before
discharge” (0 %), “PCI(percutaneous coronary interven-
tion) within 90 min of admission” (0 %), and “Thrombo-
lytic therapy within 30 min of admission” (5 %). In
addition, the compliance rate for reperfusion therapy for
STEMI(ST - segment elevation myocardial infarction)
or LBBB(left bundle branch block) patients was 75 %
and for using β-blocker within 24 h of admission was
67 %. Eighty percent, 61 and 65 % of AMI patients
were advised to continue to use aspirin, β-blocker, and
ACEI(angiotensin-converting enzyme inhibitor)/ARB
(angiotensin receptor antagonist) after discharge, re-
spectively. Forty-eight percent of inpatients without a
contraindication of heart failure did not receive β-
blockers (Table 2).
The compliance rates for the heart failure KPIs varied
widely, ranging from 1 to 100 %. Rates were lowest for
Table 2 Compliance rates for KPIs for inpatient care of AMI (n = 97)a
No Key process indicators No of Cases Compliance rate (%)
1 Timely use of aspirin or clopidogrel in appropriate dosage 95 68
2 Evaluation of left ventricular function within 24 h of admission 96 84
3 Reassessment of patient condition within one week before discharge 96 0
4 Reperfusion therapy 89 75
5 Thrombolytic therapy within 30 min of admission 97 5
6 PCI within 90 min of admission 97 0
7 Use of β-blocker within 60 min of admission 96 25
8 Use of aspirin during hospitalization 96 94
9 Use of β-blocker during hospitalization 97 73
10 USE of ACEI or ARB during hospitalizationb 97 73
11 Use of statins during hospitalization 97 93
12 Cholesterol test and lipid lowering therapy 97 27
13 Advised to continue to use aspirin after discharge 97 80
14 Advised to continue to use β-blocker after discharge 96 61
15 Advised to continue to use ACEI or ARB after discharge 94 65
16 Advised to continue to use statin after discharge 97 78
17 Advised to no smoking, having exercise, healthy eating, weight control, proper treatment of
reoccurrence or worsening, etc.
97 85
18 Smoking cessation counseling 97 85
19 Provided with written instruction on secondary prevention in discharge summary 97 84
Average 61
aKPIs key process indicators
bACEI angiotensin converting enzyme inhibitors,ARB:Angiotensin II receptor blockers
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discharge” (1 %) and for “Use of β-blockers only for
patients with chronic heart failure” (20 %). In addition,
the proportion of inpatients not using β-blockers with-
out a documented reason was 48 % (Table 3).
The compliance rates for the caesarean section KPIs
ranged from 62 to 100 %. The three KPIs with the lowest
compliance rates were “The timeliness of operation
time” (62 %), “Prophylactic use of first generation ceph-
alosporin antibiotics” (62 %), and “Delivery within 2 days
of admission” (62 %). The compliance rate for appropri-
ate use of oxytocin (10ug or 20ug) during cesarean sec-
tion was quite high (81 %) (Table 4).
The compliance rates for the type-2 diabetes KPIs
ranged from 39 to 100 %. The three KPIs with the
lowest compliance rates were “Nerve system examin-
ation” (39 %), “Glycosylated serum protein (Fructosa-
mine) test” (55 %), and “Oral glucose tolerance test
(OGTT) and insulin or C peptide release test” (58 %).
The compliance rate for HbA1c test was 91 %
(Table 5).
The compliance rates for health education for all five
diseases were relatively high (above 86 %) in the sur-
veyed hospitals (Tables 1-5).Full and average compliance rates
The proportion of patients who received fully compliant
care was low for each of the five conditions in the sur-
veyed hospitals, ranging from 0 % (AMI and heart failure)
to 39 % (pneumonia). The average compliance rates of the
KPIs ranged from 61 % (AMI) to 89 % (pneumonia). The
compliance rates among the 5 selected conditions were
significantly different (Table 6).
Discussion
Compliance rates for the five conditions
The objectives of the use of clinical pathways are to
improve quality of care, to reduce costs, and to decrease
inappropriate variation in health care use [24, 25]. Our
analysis shows, however, that the establishment of exten-
sive pathways for Chinese hospitals has not led to highly
compliant care. The proportion of patients receiving
fully compliant care ranged from 0 % (for AMI and heart
failure) to 39 % (for pneumonia). Average compliance
rates across all indicators for patients with a given condi-
tion ranged from 61 % for AMI to 89 % for pneumonia.
In our study, we considered a hospital non-compliant
for a particular indicator if the information was not
available in the medical record. Thus while the lack of
Table 4 Compliance rates of KPIs for inpatient caesarean section (n = 146)a
No Key process indicators No of Cases Compliance rate (%)
1 Appropriate indication for planned C-section 146 100
2 Preoperative examination completed within 2 days 146 99
3 Prophylactic use of first generation cephalosporin antibiotics 146 62
4 Withdraw of prophylactic antibiotics within 72 h after delivery 146 86
5 The timeliness of operation time 146 62
6 Delivery within 2 days of admission 146 62
7 Appropriate anesthesia 145 66
8 Appropriate use of oxytocin during procedure 146 81
9 Post-operative length of stay 143 99
10 In accordance with discharge standard 142 100
11 Patient received health education prior to discharge 144 89
Average 82
aKPIs key process indicators
Table 3 Compliance rates for KPIs for inpatient care of heart failure (n = 145)a
No Key process indicators No of Cases Compliance rate (%)
1 Assessment of left ventricular function within 24 h of admission 133 77
2 Assessment of left ventricular function 1 week prior to discharge 121 1
3 Timely use of diuretics and potassium agents 140 96
4 Timely use of ACEI or ARBb 145 87
5 Use of β-blockers only for patients with CHFc 133 20
6 Use of aldosterone receptor blockers only for patients with severe health failured 142 85
7 Continued use of diuretics during hospitalization 145 93
8 Continued use of ACEI or ARB during hospitalization 144 87
9 Continued use of β-blocker during hospitalization 129 53
10 Continued use of aldosterone receptor blockers during hospitalization 139 84
11 Advised to use diuretics after discharge 139 82
12 Advised to use ACEI or ARB after discharge 140 76
13 Advised to use β-blocker after discharge 126 54
14 Advised to use aldosterone receptor blockers after discharge 134 78
15 Record of heart failure education 145 100
16 Assessment of cardiac function and living ability, and guidance activities after admission 145 100
17 Proper observation of patients (including symptoms, vital signs, water balance, weight, edema),
provision of laboratory tests, and advice on diet and body-position after admission.
144 100
18 Assessment of tobacco and alcohol addiction after admission and Patient advised to quit smoking
and to restrict alcohol consumption
145 54
19 Patient received psychological counseling 145 59
20 Patient advised on activity limitations after discharge 144 100
21 Patient received dietary and body-position guidance prior to discharge 143 100
22 Patient advised to quit smoking and to restrict alcohol consumption prior to discharge 143 99
Average 78
aKPIs key process indicators
bACEI angiotensin converting enzyme inhibitors, ARB angiotensin II receptor blockers
cCHF chronic heart failure
dSevere heart failure refers to the New York Heart Association (NYHA) cardiac function proposed test (NYHA functional) III, IV level of the patients
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Table 5 Compliance rates of KPIs for inpatient care of type-2 diabetes (n = 137)a
No Key process indicators No of Cases Compliance rate (%)
1 Routine examination within 24 h after admission 137 100
2 Blood glucose monitoring 7 times per day 137 64
3 HbA1c test 137 91
4 Glycosylated Serum Protein (Fructosamine) test 136 55
5 OGTT and insulin or C peptide release testb 137 58
6 Eye fundus examination 137 62
7 Nerve system examination 137 39
8 Renal function examination 137 83
9 Heart ultrasound examination 137 72
10 Carotid artery and lower extremity vascular ultrasound examination 137 73
11 Blood glucose test analyzed 137 97
12 Evaluation at 72 h after hypoglycemic treatment 137 85
13 Record of drug selection reasons 137 99
14 Record of secondary prevention and health education provided to patient 137 98
15 In accordance with discharge standard 137 96
16 Appropriate length of stay 137 88
Average 79
aKPIs key process indicators
bOGTT oral glucose tolerance test
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by non-compliant care, it could also be due to a lack of
documentation. It is possible that the care patients re-
ceive may be more compliant with clinical pathways
than our results suggest, and that hospitals could poten-
tially improve their measured performance through bet-
ter documentation.
It is also possible that our findings are influenced by
the timing of the study. The national pathways were is-
sued relatively recently in 2009 and the importance of
adhering to pathways may not have been fully valued by
hospital managers in 2012. A qualitative study of the use
of clinical pathways in Chinese hospitals identified lackTable 6 Analysis on compliance rate for inpatient care
Full compliance rate
Indicators No of KPIsa Number of cases Number of fully
compliant cases
Pe
Pneumonia 8 150 58
AMI 19 80 0
Heart failure 22 76 0
Caesarean 11 139 32
Type-2 diabetes 16 136 3
Total 76 581 93
χ2 111.37***
Pfisher’s exact test 1.560E-26
***P < 0.01
aKPIs Key Process Indicatorsof leadership and support for implementing clinical
pathways as barriers to compliance [26].
Low rates of compliance with clinical pathways could
also reflect physician concerns over the quality of the
pathway. The quality of clinical pathways is dependent
upon the quality of the underlying evidence, and, for
many clinical applications, the evidence base is inad-
equate. Even in situations with adequate evidence, clin-
ical pathways could adversely affect patient care if the
evidence is not translated effectively into the clinical
pathways. In addition, simplistic clinical pathways may
not accommodate heterogeneity of patients in practice.
An alternative explanation for low rates of compliance isAverage compliance rate
rcent (%) Average number
of cases for KPVs
Average cases that meet
the requirement for KPVs
Percent (%)
39 151 134 89
0 96 59 61
0 139 108 78
23 145 119 82
2 137 108 79
16 668 528 79
27.45***
2.783E-05
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compliant care is inappropriate for patients.
We note that we evaluated whether care was consist-
ent with national pathways but did not evaluate whether
the national pathways were appropriate. Similarly, hospi-
tals were able to customize the national pathways for
their local setting, providing another potential explan-
ation for the deviations from the national pathways that
we observed [22]. Determining the extent to which the
pathways represent appropriate care is important for
evaluating the desirability of increasing rates of compli-
ance with national pathways.
Clinical pathways may also be difficult to implement.
Physicians may be concerned that using clinical path-
ways will reduce their autonomy. Other barriers include
a lack of incentives to change practice styles, unclear ac-
countability for health outcomes, competing priorities,
lack of resources, health funding constraints, regulation
and patient factors (clinical contraindications or history
of intolerance to a recommended medication, patient
refusal), difficulty coordinating across providers and cul-
tural barriers [6, 26–30]. Correspondingly, studies gener-
ally document relatively low levels of compliance with
clinical pathways although compliance level varies sub-
stantially across sites and across measures.
In our study, differences across conditions in the degree
of compliance may have been driven by condition com-
plexity. For example, in the case of pneumonia, treatment
does not vary much across patients. In the case of AMI, in
contrast, not only is treatment urgent, but guideline com-
pliant care varies significantly across patients. Similarly,
heart failure is more complex than cesarean section. Con-
sistent with this explanation, we found the highest rates of
non-compliance among AMI and heart failure patients,
the two most complex conditions we studied.Comparison of compliance rates with other countries
The compliance rates for process indicators in public
general hospitals of Pudong new area were higher than
those from studies from other countries in some cases
and were similar or lower in others. For example, 92 %
of patients with pneumonia in our study received initial
antibiotics within 4 h of hospital arrival, compared to
81 % within 8 h in a study in the U.S. [20]. According to
our chart review, 91 % of type-2 diabetics received an
HbA1c test, but this rate was about 32 % in the hospitals
in the eastern province of Saudi Arabia [31].
But, for patients with AMI, only 5 % received thrombo-
lytic therapy within 30 min of admission, 0 % received PCI
within 90 min of admission, and 61 % were advised to
continue to use β-blocker after discharge, much lower
than corresponding rates in U.S. studies (36, 70 and 79 %,
respectively) [13]. The proportion of inpatients with heartfailure inappropriately not using β-blockers in our study
was 48 %, much higher than that in the U.S. (15 %) [27].
The compliance rates for using β-blocker within 24 h,
for advising to continue to use aspirin after discharge,
and for advising to continue to use ACEI/ARB after
discharge for AMI in our study were 67, 80, and 65 %,
similar to those in US and French studies (59.5–74 %,
72–87 %, 53–80 %) [13–15, 32, 33].
The compliance rate for appropriate use of oxytocin
during cesarean section was quite high (81 %). In con-
trast, a survey of 306 clinicians on the implementation
of a pathway on oxytocin use during cesarean section in
England and Wales found that only 40 % of the surveyed
clinicians followed the NICE recommendation [34].
While these comparisons should be interpreted with cau-
tion since they are based on studies of different time
periods and clinical practice changes rapidly, they point to
important differences across countries in the extent to
which health care organizations provide pathway compli-
ant care.Limitations
The findings of this study were based on chart review of
5 common conditions in inpatient care of 7 public gen-
eral hospitals of Pudong new area in Shanghai. As a re-
sult, the study results may not represent the experience of
other areas or regions of China, although they are likely to
reflect medical practice in Shanghai. We emphasize, how-
ever, that Pudong New Area includes both urban and rural
areas, indicating that our study sample includes econom-
ically diverse patients. In general, because the socioeco-
nomic status is higher and more resources are devoted to
health care in eastern China than in other areas, the study
results are likely to represent an area in China with rela-
tively high quality of care.Conclusions
Evidence-based clinical pathways may be used to improve
quality of care, reduce costs, and decrease inappropriate
variation in clinical practice. But our study found that
public general hospitals in Shanghai had low compliance
with national clinical pathways for 5 common conditions
(pneumonia, AMI, heart failure, cesarean section, type-2
diabetes). The results, which provide unique evidence of
the state of quality of care in Chinese public hospitals,
indicate that opportunities exist to improve quality of care
in Chinese public hospitals.
Our study also suggests that Chinese public hospitals
could use the clinical pathways established by the NHFPC
as a tool to identify areas in which quality could be
improved. Our audit study identified certain KPIs for
which Chinese hospitals performed well and others for
which they did not. This information could be used to
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improvement activities.
Finally, our results suggest that opportunities exist for
the NHFPC to create and for hospitals to use clinical
pathways more effectively. Our findings indicated that
hospitals in Shanghai often do not provide care consist-
ent with clinical pathways. More research is necessary to
determine if the pathways are appropriate and, if so,
how to encourage hospitals to change processes of care
to be consistent with the guidelines.
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